Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine

Joseph A. Bocchini; Robert S. Baltimore; Henry H. Bernstein; John S. Bradley; Michael T. Brady; Penelope H. Dennehy; Margaret C. Fisher; Robert W. Frenck; David W. Kimberlin; Sarah S. Long; Julia A. McMillan; Lorry G. Rubin; Richard D. Clover; Marc A. Fischer; Richard L. Gorman; Douglas R. Pratt; Anne Schuchat; Benjamin Schwartz; Jeffrey R. Starke; Jack Swanson; Larry K. Pickering; Edgar O. Ledbetter; Alison Siwek

doi:10.1542/peds.2006-3134

Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine

Joseph A. Bocchini, Robert S. Baltimore, Henry H. Bernstein, John S. Bradley, Michael T. Brady, Penelope H. Dennehy, Margaret C. Fisher, Robert W. Frenck, David W. Kimberlin, Sarah S. Long, Julia A. McMillan, Lorry G. Rubin, Richard D. Clover, Marc A. Fischer, Richard L. Gorman, Douglas R. Pratt, Anne Schuchat, Benjamin Schwartz, Jeffrey R. Starke, Jack SwansonLarry K. Pickering, Edgar O. Ledbetter, Alison Siwek

School of Medicine

Research output: Contribution to journal › Review article › peer-review

59 Scopus citations

Abstract

On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.

Original language	English (US)
Pages (from-to)	171-181
Number of pages	11
Journal	Pediatrics
Volume	119
Issue number	1
DOIs	https://doi.org/10.1542/peds.2006-3134
State	Published - Jan 2007

Keywords

Rotavirus gastroenteritis
Rotavirus vaccine

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1542/peds.2006-3134

Cite this

Bocchini, J. A., Baltimore, R. S., Bernstein, H. H., Bradley, J. S., Brady, M. T., Dennehy, P. H., Fisher, M. C., Frenck, R. W., Kimberlin, D. W., Long, S. S., McMillan, J. A., Rubin, L. G., Clover, R. D., Fischer, M. A., Gorman, R. L., Pratt, D. R., Schuchat, A., Schwartz, B., Starke, J. R., ... Siwek, A. (2007). Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine. Pediatrics, 119(1), 171-181. https://doi.org/10.1542/peds.2006-3134

Bocchini, JA, Baltimore, RS, Bernstein, HH, Bradley, JS, Brady, MT, Dennehy, PH, Fisher, MC, Frenck, RW, Kimberlin, DW, Long, SS, McMillan, JA, Rubin, LG, Clover, RD, Fischer, MA, Gorman, RL, Pratt, DR, Schuchat, A, Schwartz, B, Starke, JR, Swanson, J, Pickering, LK, Ledbetter, EO & Siwek, A 2007, 'Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine', Pediatrics, vol. 119, no. 1, pp. 171-181. https://doi.org/10.1542/peds.2006-3134

@article{315616e7ac5f44569775b2dafc3f5d18,

title = "Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine",

abstract = "On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.",

keywords = "Rotavirus gastroenteritis, Rotavirus vaccine",

author = "Bocchini, {Joseph A.} and Baltimore, {Robert S.} and Bernstein, {Henry H.} and Bradley, {John S.} and Brady, {Michael T.} and Dennehy, {Penelope H.} and Fisher, {Margaret C.} and Frenck, {Robert W.} and Kimberlin, {David W.} and Long, {Sarah S.} and McMillan, {Julia A.} and Rubin, {Lorry G.} and Clover, {Richard D.} and Fischer, {Marc A.} and Gorman, {Richard L.} and Pratt, {Douglas R.} and Anne Schuchat and Benjamin Schwartz and Starke, {Jeffrey R.} and Jack Swanson and Pickering, {Larry K.} and Ledbetter, {Edgar O.} and Alison Siwek",

year = "2007",

month = jan,

doi = "10.1542/peds.2006-3134",

language = "English (US)",

volume = "119",

pages = "171--181",

journal = "Pediatrics",

issn = "0031-4005",

publisher = "American Academy of Pediatrics",

number = "1",

}

TY - JOUR

T1 - Prevention of rotavirus disease

T2 - Guidelines for use of rotavirus vaccine

AU - Bocchini, Joseph A.

AU - Baltimore, Robert S.

AU - Bernstein, Henry H.

AU - Bradley, John S.

AU - Brady, Michael T.

AU - Dennehy, Penelope H.

AU - Fisher, Margaret C.

AU - Frenck, Robert W.

AU - Kimberlin, David W.

AU - Long, Sarah S.

AU - McMillan, Julia A.

AU - Rubin, Lorry G.

AU - Clover, Richard D.

AU - Fischer, Marc A.

AU - Gorman, Richard L.

AU - Pratt, Douglas R.

AU - Schuchat, Anne

AU - Schwartz, Benjamin

AU - Starke, Jeffrey R.

AU - Swanson, Jack

AU - Pickering, Larry K.

AU - Ledbetter, Edgar O.

AU - Siwek, Alison

PY - 2007/1

Y1 - 2007/1

N2 - On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.

AB - On February 3, 2006, a bovine-based pentavalent rotavirus vaccine (RotaTeq, Merck & Co Inc, Whitehouse Station, NJ) was licensed by the US Food and Drug Administration for use in infants in the United States. The American Academy of Pediatrics recommends routine immunization of infants with 3 doses of pentavalent rotavirus vaccine administered orally at 2, 4, and 6 months of age. The first dose should be administered between 6 and 12 weeks of age; immunization should not be initiated for infants older than 12 weeks of age. Subsequent doses should be administered at 4- to 10-week intervals, and all 3 doses of vaccine should be administered by 32 weeks of age. Pentavalent rotavirus vaccine can be coadministered with other childhood vaccines. Pentavalent rotavirus vaccine is contraindicated for infants with a serious allergic reaction to any vaccine component or to a previous dose of vaccine.

KW - Rotavirus gastroenteritis

KW - Rotavirus vaccine

UR - http://www.scopus.com/inward/record.url?scp=33846938614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846938614&partnerID=8YFLogxK

U2 - 10.1542/peds.2006-3134

DO - 10.1542/peds.2006-3134

M3 - Review article

C2 - 17200286

AN - SCOPUS:33846938614

SN - 0031-4005

VL - 119

SP - 171

EP - 181

JO - Pediatrics

JF - Pediatrics

IS - 1

ER -

Prevention of rotavirus disease: Guidelines for use of rotavirus vaccine

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this